請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/81998完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 陳為堅(Wei J. Chen) | |
| dc.contributor.author | Wei-Yi Tsay | en |
| dc.contributor.author | 蔡韙伊 | zh_TW |
| dc.date.accessioned | 2022-11-25T05:33:49Z | - |
| dc.date.available | 2023-08-21 | |
| dc.date.copyright | 2021-09-16 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-08-21 | |
| dc.identifier.citation | Abolhassani, N., Haba-Rubio, J., Heinzer, R., Vollenweider, P., Marques-Vidal, P. (2019). Ten-Year trend in sleeping pills use in Switzerland: the CoLaus study. Sleep medicine, 64, 56-61. Agravat, A. (2018). ‘Z’‐hypnotics versus benzodiazepines for the treatment of insomnia. Progress in Neurology and Psychiatry, 22(2), 26-29. Bachhuber, M. A., Hennessy, S., Cunningham, C. O., Starrels, J. L. (2016). Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996–2013. American journal of public health, 106(4), 686-688. Becker, W. C., Fiellin, D. A., Desai, R. A. (2007). Non-medical use, abuse and dependence on sedatives and tranquilizers among US adults: psychiatric and socio-demographic correlates. Drug and alcohol dependence, 90(2-3), 280-287. Bertisch, S. M., Herzig, S. J., Winkelman, J. W., Buettner, C. (2014). National use of prescription medications for insomnia: NHANES 1999-2010. Sleep, 37(2), 343-349. Blanco, C., Han, B., Jones, C. M., Johnson, K., Compton, W. M. (2018). Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States. The Journal of clinical psychiatry, 79(6), 0-0. Blanco, C., Rubio, J., Wall, M., Wang, S., Jiu, C. J., Kendler, K. S. (2014). Risk factors for anxiety disorders: common and specific effects in a national sample. Depression and anxiety, 31(9), 756-764. Brandt, J., Alessi-Severini, S., Singer, A., Leong, C. (2019). Novel measures of Benzodiazepine z-drug utilisation trends in a Canadian provincial adult population (2001-2016). Journal of Population Therapeutics and Clinical Pharmacology, 26(1), e22-e38. Brandt, J., Leong, C. (2017). Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research. Drugs in R D, 17(4), 493-507. Bye, E. K., Rossow, I. (2017). Concomitant alcohol and sedative-hypnotic drug use among the elderly in Norway. Nordic Studies on Alcohol and Drugs, 34(1), 18-27. Chang, L. J. (2015). Potential dangers of the prescription and use of sedatives/hypnotics: from the perspective of one kind of sedatives/hypnotics consumed annually over 100 million in Taiwan. Chen, C. H., Chen, W. J., Cheng, A. T. (2005). New approach to the validity of the alcohol use disorders identification test: stratum‐specific likelihood ratios analysis. Alcoholism: Clinical and Experimental Research, 29(4), 602-608. Chen, L.-Y., Chen, Y.-L., Tsay, W.-I., Wu, S.-C., Chen, Y.-T., Hsiao, P.-C., Yu, Y.-H., Ting, T.-T., Chen, C.-Y., Tu, Y.-K. (2019). Nonmedical prescription drug use of analgesics and sedatives/hypnotics in Taiwan: Results from the 2014 National Survey of Substance Use. Preventive medicine reports, 15, 100900. Chen, W. J., Wu, S.-C., Tsay, W.-I., Chen, Y.-T., Hsiao, P.-C., Yu, Y.-H., Ting, T.-T., Chen, C.-Y., Tu, Y.-K., Huang, J.-H. (2017). Differences in prevalence, socio-behavioral correlates, and psychosocial distress between club drug and hard drug use in Taiwan: Results from the 2014 National Survey of Substance Use. International Journal of Drug Policy, 48, 99-107. Chien, I.-C., Bih, S.-H., Chou, Y.-J., Lin, C.-H., Lee, W.-G., Chou, P. (2007). Trends in the use of psychotropic drugs in Taiwan: a population-based national health insurance study, 1997–2004. Psychiatric services, 58(4), 554-557. Dolder, C. R., Nelson, M. H. (2008). Hypnosedative-induced complex behaviours. CNS drugs, 22(12), 1021-1036. Grigg, J., Lenton, S., Scott, J., Barratt, M. (2015). Social supply of cannabis in Australia. National Drug and Law Enforcement Research Fund (NDLERF), Canberra. Gunja, N. (2013). The clinical and forensic toxicology of Z-drugs. Journal of Medical Toxicology, 9(2), 155-162. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., Fagerstrom, K. O. (1991). The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. British journal of addiction, 86(9), 1119-1127. Hou, C.-C., Chen, S.-C., Tan, L.-B., Chu, W.-Y., Huang, C.-M., Liu, S.-Y., Chen, K.-T. (2012). Psychoactive substance use and the risk of motor vehicle crash injuries in southern Taiwan. Prevention science, 13(1), 36-42. Huang, B., Dawson, D. A., Stinson, F. S., Hasin, D. S., Ruan, W. J., Saha, T. D., Smith, S. M., Goldstein, R. B., Grant, B. F. (2006). Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: Results of the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of clinical psychiatry, 67(7), 0-0. Hulme, S., Bright, D., Nielsen, S. (2018). The source and diversion of pharmaceutical drugs for non-medical use: a systematic review and meta-analysis. Drug and alcohol dependence, 186, 242-256. Iza, M., Olfson, M., Vermes, D., Hoffer, M., Wang, S., Blanco, C. (2013). Probability and predictors of first treatment contact for anxiety disorders in the United States: analysis of data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The Journal of clinical psychiatry, 74(11), 1093-1100. Kang, K. H., Chen, W. J. (unpublished data). Klink, M. E., Quan, S. F., Kaltenborn, W. T., Lebowitz, M. D. (1992). Risk factors associated with complaints of insomnia in a general adult population: influence of previous complaints of insomnia. Archives of internal medicine, 152(8), 1634-1637. Kurko, T., Saastamoinen, L. K., Tuulio‐Henriksson, A., Taiminen, T., Tiihonen, J., Airaksinen, M., Hietala, J. (2018). Trends in the long‐term use of benzodiazepine anxiolytics and hypnotics: A national register study for 2006 to 2014. Pharmacoepidemiology and drug safety, 27(6), 674-682. Laia, S.-W. (2016). Risks and benefits of zolpidem use in Taiwan: a narrative review. Biomedicine, 6(2), 1-3. Lee, M. H., Choi, J.-W., Lee, J., Shin, A., Oh, S. M., Jung, S. J., Lee, Y. J. (2019). Trends in prescriptions for sedative–hypnotics among Korean adults: a nationwide prescription database study for 2011–2015. Social psychiatry and psychiatric epidemiology, 54(4), 477-484. Maust, D. T., Lin, L. A., Blow, F. C. (2019). Benzodiazepine use and misuse among adults in the United States. Psychiatric services, 70(2), 97-106. McCabe, S. E., Teter, C. J., Boyd, C. J., Wilens, T. E., Schepis, T. S. (2018). Sources of prescription medication misuse among young adults in the United States: the role of educational status. The Journal of clinical psychiatry, 79(2), 0-0. Ministry of Health and Welfare. (2012). Announcement of MOHW (健保審字第1010076053 號). Ministry of Health and Welfare. (2013). Announcement of MOHW (部授食字第1021452225A號). Ministry of Health and Welfare. (2020). Announcement of MOHW (衛授食字第1091402653號). Ministry of the Interior. (2020). Bulletin of internal affairs statistics for the 12th week of 109. Retrieved from https://www.moi.gov.tw/cp.aspx?n=10492 Moloney, M. E., Konrad, T. R., Zimmer, C. R. (2011). The medicalization of sleeplessness: a public health concern. American journal of public health, 101(8), 1429-1433. Olfson, M., King, M., Schoenbaum, M. (2015). Benzodiazepine use in the United States. JAMA psychiatry, 72(2), 136-142. Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied psychological measurement, 1(3), 385-401. Schifano, F., Chiappini, S., Corkery, J. M., Guirguis, A. (2019). An insight into Z-drug abuse and dependence: an examination of reports to the European medicines agency database of suspected adverse drug reactions. International Journal of Neuropsychopharmacology, 22(4), 270-277. Shi, W., Shen, Z., Wang, S., Hall, B. J. (2020). Barriers to professional mental health help-seeking among Chinese adults: a systematic review. Frontiers in psychiatry, 11, 442. Smink, B. E., Egberts, A. C., Lusthof, K. J., Uges, D. R., De Gier, J. J. (2010). The relationship between benzodiazepine use and traffic accidents. CNS drugs, 24(8), 639-653. Taiwan Food and Drug Administration. (2012). Trends in controlled drug consumption in Taiwan, 2002-2011. Retrieved from https://www.grb.gov.tw/search/planDetail?id=2468108 Taiwan Society of Sleep Medicine. (2006-2017). The Taiwanese Sleep Survey. Retrieved from http://www.tssm.org.tw/resource_03.php U.S. Food and Drug Administration. (2019). FDA adds Boxed Warning for risk of serious injuries caused by sleepwalking with certain prescription insomnia medicines. Retrieved from https://www.fda.gov/drugs/drug-safety-and-availability/fda-adds-boxed-warning-risk-serious-injuries-caused-sleepwalking-certain-prescription-insomnia Uchida, T., Hirano, J., Sakurai, H., Suzuki, T., Mimura, M., Uchida, H. (2019). Concomitant use of alcohol and benzodiazepine hypnotics in psychiatric outpatients: a cross-sectional survey. International clinical psychopharmacology, 34(6), 291-297. United Nations Office on Drugs and Crime. (2011). The Non‐medical use of prescription drugs: Policy direction issues. Retrieved from https://www.unodc.org/documents/drug-prevention-and-treatment/nonmedical-use-prescription-drugs.pdf Votaw, V. R., Geyer, R., Rieselbach, M. M., McHugh, R. K. (2019). The epidemiology of benzodiazepine misuse: a systematic review. Drug and alcohol dependence, 200, 95-114. Wagner, A. K., Zhang, F., Soumerai, S. B., Walker, A. M., Gurwitz, J. H., Glynn, R. J., Ross-Degnan, D. (2004). Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Archives of internal medicine, 164(14), 1567-1572. Wang, L.-J., Chen, Y.-C., Chen, C.-K., Chou, W.-J., Chou, M.-C. (2014). Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002–2009: a nationwide, population-based survey. Psychiatric services, 65(2), 208-214. Yang, H.-J., Soong, W.-T., Kuo, P.-H., Chang, H.-L., Chen, W. J. (2004). Using the CES-D in a two-phase survey for depressive disorders among nonreferred adolescents in Taipei: a stratum-specific likelihood ratio analysis. Journal of affective disorders, 82(3), 419-430. Yoshioka, E., Saijo, Y., Kita, T., Satoh, H., Kawaharada, M., Fukui, T., Kishi, R. (2012). Gender differences in insomnia and the role of paid work and family responsibilities. Social psychiatry and psychiatric epidemiology, 47(4), 651-662. Yudko, E., Lozhkina, O., Fouts, A. (2007). A comprehensive review of the psychometric properties of the Drug Abuse Screening Test. Journal of substance abuse treatment, 32(2), 189-198. Zhabenko, O., Austic, E., Conroy, D. A., Ehrlich, P., Singh, V., Epstein-Ngo, Q., Cunningham, R. M., Walton, M. A. (2016). Substance use as a risk factor for sleep problems among adolescents presenting to the emergency department. Journal of addiction medicine, 10(5), 331. Zhang, Z., Sun, K., Jatchavala, C., Koh, J., Chia, Y., Bose, J., Li, Z., Tan, W., Wang, S., Chu, W. (2020). Overview of stigma against psychiatric illnesses and advancements of anti-stigma activities in six Asian societies. International journal of environmental research and public health, 17(1), 280. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/81998 | - |
| dc.description.abstract | "背景及目的 為了因應鎮靜安眠藥使用與非醫療使用日益增加的擔憂，台灣有關鎮靜安眠藥相關的規定隨時間也越來越嚴格。然而，針對台灣一般族群及在各人口學分層中，自陳式的鎮靜安眠藥使用與非醫療使用的趨勢仍舊不清楚。此外，關於鎮靜安眠藥非醫療使用的來源與動機的研究也相當缺乏。利用2014年與2018年台灣全國物質使用調查結果，此研究之目的為：(1) 探討整體以及在性別與年齡分層下，兩波調查過去一年鎮靜安眠藥使用及非醫療使用的趨勢；(2) 並檢查社會人口學特性、其他物質使用和憂鬱程度與觀察到的趨勢之關係；(3) 更進一步探討過去一年自陳非醫療使用的來源與動機為何。 方法 研究資料為2014年與2018年全國物質使用調查，此為一針對12-64歲居民並具全國代表性樣本的調查。在2014年納入共17,837名受訪者（完訪率為62.2%），而在2018年則納入共18,626名受訪者（完訪率為64.6%）。每位受訪者皆須以匿名與輔助式自我訪談方式填答一份涵蓋人口學變項、成癮性物質和鎮靜安眠藥使用等資訊的問卷。鎮靜安眠藥的非醫療使用定義為曾在未獲得醫師處方、使用頻率較高、或使用劑量較大之情況下使用藥物。利用雙尾z分數檢定來檢查兩波調查的盛行率是否有顯著改變，並使用差異中之差異法來確認在趨勢間是否存在性別差異。 結果 從2014年至2018年，台灣過去一年鎮靜安眠藥使用與非醫療使用的整體盛行率皆未有顯著改變。然而，12-34歲年齡組的鎮靜安眠藥使用趨勢以及35-64歲年齡組的非醫療使用趨勢存在著性別差異。在鎮靜安眠藥的使用，男性的盛行率邊緣性顯著地減少0.49%，女性的盛行率則顯著地增加0.90%。且這些趨勢間的性別差異可能與單身與酒精使用的比例改變有關。而在鎮靜安眠藥的非醫療使用，男性的盛行率顯著地減少0.37%，女性的盛行率則顯著地增加0.45%。針對過去一年非醫療使用者，由親戚或朋友來源取得鎮靜安眠藥的情況顯著增加，且最常見的使用動機仍是自我治療。 結論 台灣從2014年至2018年，過去一年鎮靜安眠藥使用與非醫療使用的趨勢在不同的年齡組存在著性別差異。對於非醫療使用者，由親戚或朋友來源取得藥物的狀況增加，且自我治療仍是最常見的動機。我們的研究結果對於介入與預防鎮靜安眠藥的使用與非醫療使用具有重要的意義。" | zh_TW |
| dc.description.provenance | Made available in DSpace on 2022-11-25T05:33:49Z (GMT). No. of bitstreams: 1 U0001-2108202113054500.pdf: 1390893 bytes, checksum: 85ce8ad4558571a01f9f3cd0d6efd0c7 (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 致謝 i 中文摘要 ii Abstract iv Contents vii List of tables viii List of figures ix List of appendices x Chapter 1 Introduction 1 Chapter 2 Materials and Methods 6 2.1 Participants 6 2.2 Measurements 7 2.3 Statistical analyses 10 Chapter 3 Results 12 3.1 Past-year use and NMU of sedatives/hypnotics 12 3.2 Possible reasons for the gender differences 14 3.3 Increase in use of sedatives/hypnotics among females aged 12-34 years 16 3.4 Trends in use and NMU by different types of sedatives/hypnotics 17 3.5 Sources and motives among past-year nonmedical users 17 Chapter 4 Discussion 18 4.1 Gender difference in the trends of past-year use 18 4.2 Gender difference in the trends of past-year NMU 21 4.3 Trends stratified by drug types 22 4.4 Trends in the sources and motives of past-year nonmedical users 24 4.5 Strengths and limitations 26 4.6 Conclusions 27 Reference 29 Appendices 40 | |
| dc.language.iso | en | |
| dc.subject | 台灣 | zh_TW |
| dc.subject | 鎮靜安眠藥 | zh_TW |
| dc.subject | 非醫療使用 | zh_TW |
| dc.subject | 調查 | zh_TW |
| dc.subject | 趨勢 | zh_TW |
| dc.subject | 性別差異 | zh_TW |
| dc.subject | 年齡組 | zh_TW |
| dc.subject | sedatives/hypnotics | en |
| dc.subject | Taiwan | en |
| dc.subject | age group | en |
| dc.subject | gender differences | en |
| dc.subject | trends | en |
| dc.subject | survey | en |
| dc.subject | nonmedical use | en |
| dc.title | 從2014年至2018年臺灣民眾一年內有服用鎮靜安眠藥經驗之趨勢：性別與年齡的影響 | zh_TW |
| dc.title | Trends in Past-year Use of Prescription Sedatives/Hypnotics from 2014 to 2018 in Taiwan: Influence of Gender and Age | en |
| dc.date.schoolyear | 109-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 陳亮妤(Hsin-Tsai Liu),吳其炘(Chih-Yang Tseng),陳娟瑜 | |
| dc.subject.keyword | 鎮靜安眠藥,非醫療使用,調查,趨勢,性別差異,年齡組,台灣, | zh_TW |
| dc.subject.keyword | sedatives/hypnotics,nonmedical use,survey,trends,gender differences,age group,Taiwan, | en |
| dc.relation.page | 49 | |
| dc.identifier.doi | 10.6342/NTU202102568 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2021-08-23 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 流行病學與預防醫學研究所 | zh_TW |
| dc.date.embargo-lift | 2023-08-21 | - |
| 顯示於系所單位： | 流行病學與預防醫學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-2108202113054500.pdf 授權僅限NTU校內IP使用（校園外請利用VPN校外連線服務） | 1.36 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。